pI: 7.6127 |
Length (AA): 435 |
MW (Da): 47596 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_128801)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G49640 | aldolase-type TIM barrel family protein |
Brugia malayi | Bm1_02370 | dihydrouridine synthase domain containing protein |
Candida albicans | CaO19.8942 | potential dihydrouridine synthase similar to S. cerevisiae SMM1/DUS2 (YNR015W) dihydrouridine synthase specific for pre-tRNA-Leu |
Candida albicans | CaO19.1362 | potential dihydrouridine synthase similar to S. cerevisiae SMM1/DUS2 (YNR015W) dihydrouridine synthase specific for pre-tRNA-Leu |
Caenorhabditis elegans | CELE_Y54E5A.6 | Protein Y54E5A.6 |
Dictyostelium discoideum | DDB_G0283877 | tRNA-dihydrouridine synthase 2-like protein |
Drosophila melanogaster | Dmel_CG1434 | CG1434 gene product from transcript CG1434-RB |
Echinococcus granulosus | EgrG_000169500 | tRNA dihydrouridine synthase 2 |
Entamoeba histolytica | EHI_023240 | dihydrouridine synthase (Dus) family protein |
Echinococcus multilocularis | EmuJ_000169500 | tRNA dihydrouridine synthase 2 |
Homo sapiens | ENSG00000167264 | dihydrouridine synthase 2 |
Leishmania braziliensis | LbrM.35.0560 | dihydrouridine synthase domain protein-like protein |
Leishmania donovani | LdBPK_360500.1 | dihydrouridine synthase domain protein-like protein |
Leishmania infantum | LinJ.36.0500 | dihydrouridine synthase domain protein-like protein |
Leishmania major | LmjF.36.0470 | dihydrouridine synthase domain protein-like protein |
Leishmania mexicana | LmxM.36.0470 | dihydrouridine synthase domain protein-like protein |
Loa Loa (eye worm) | LOAG_03826 | dihydrouridine synthase domain-containing protein |
Mus musculus | ENSMUSG00000031901 | dihydrouridine synthase 2 |
Neospora caninum | NCLIV_019410 | GH10224, related |
Oryza sativa | 4336488 | Os04g0531300 |
Saccharomyces cerevisiae | YNR015W | Smm1p |
Schistosoma japonicum | Sjp_0204740 | ko:K05543 tRNA-dihydrouridine synthase 2, putative |
Schistosoma mansoni | Smp_149450 | tRNA-dihydrouridine synthase |
Schmidtea mediterranea | mk4.013053.00 | tRNA-dihydrouridine(20) synthase |
Schmidtea mediterranea | mk4.014238.00 | tRNA-dihydrouridine(20) synthase |
Trypanosoma brucei gambiense | Tbg972.10.5920 | tRNA-dihydrouridine synthase 2, putative |
Trypanosoma brucei | Tb927.10.4870 | tRNA-dihydrouridine synthase 2, putative |
Trypanosoma brucei | Tb11.v5.0899 | tRNA-dihydrouridine synthase 2, putative |
Trypanosoma congolense | TcIL3000_10_4060 | tRNA-dihydrouridine synthase 2, putative |
Trypanosoma cruzi | TcCLB.504203.29 | tRNA-dihydrouridine synthase 2, putative |
Trypanosoma cruzi | TcCLB.503791.40 | dihydrouridine synthase, putative |
Toxoplasma gondii | TGME49_280780 | dihydrouridine synthase (dus) protein |
Trichomonas vaginalis | TVAG_292590 | tRNA-dihydrouridine synthase, putative |
Trichomonas vaginalis | TVAG_255860 | tRNA-dihydrouridine synthase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.4870 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.4870 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.4870 this record | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.4870 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_280780 | Toxoplasma gondii | Essentiality uncertain | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | dihydrouridine synthase 2 | Compounds | References |
1 literature reference was collected for this gene.